Search

everythinglearnresearchcommunity

for

Search:↓

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Platelet-rich treatments can help improve wound healing and tissue repair.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

A specific type of skin cell creates an opening for hair to grow out, and problems with this process can lead to skin conditions.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Applying a specific inhibitor lightens skin and hair color.

Smad-4 and Smad-7 are key in hair follicle development, with other Smads being less important.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Certain drugs that block specific enzymes can help treat prostate diseases.

Mice with human skin protein K8 had more skin problems and cancer.